Media coverage
11
Media coverage
Title New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines’ ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis Media name/outlet Business Wire Country/Territory United States Date 19/05/24 URL https://www.businesswire.com/news/home/20240519406386/en/New-Phase-2a-Clinical-Trial-Results-Demonstrate-Endeavor-BioMedicines%E2%80%99-ENV-101-Improved-Lung-Function-and-Reversed-Key-Measures-of-Lung-Fibrosis-in-Patients-With-Idiopathic-Pulmonary-Fibrosis Persons Michael Maher Title New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines' ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis; Data presented for the first time today during late-breaking o Media name/outlet Business Wire Country/Territory United States Date 19/05/24 Persons Michael Maher Title New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines’ ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis Media name/outlet BioSpace Country/Territory United States Date 19/05/24 URL https://www.biospace.com/article/releases/new-phase-2a-clinical-trial-results-demonstrate-endeavor-biomedicines-env-101-improved-lung-function-and-reversed-key-measures-of-lung-fibrosis-in-patients-with-idiopathic-pulmonary-fibrosis/ Persons Michael Maher Title New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines’ ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis Media name/outlet APNews.com Country/Territory United States Date 19/05/24 URL https://apnews.com/press-release/business-wire/lung-disease-clinical-trials-3539a71707864c73b74999bf836ba3ae Persons Michael Maher Title New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines’ ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis Media name/outlet Yahoo! Finanzas Country/Territory United States Date 19/05/24 URL https://es-us.finanzas.yahoo.com/news/phase-2a-clinical-trial-results-181200925.html Persons Michael Maher Title New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines’ ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis Media name/outlet ADVFN US Country/Territory United States Date 19/05/24 URL https://www.advfn.com/stock-market/stock-news/93885292/new-phase-2a-clinical-trial-results-demonstrate-endeavor-biomedicines-env-101 Persons Michael Maher Title New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines' ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis Media name/outlet Le Lezard.com Country/Territory Canada Date 19/05/24 URL https://www.lelezard.com/en/news-21383975.html Persons Michael Maher Title New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines’ ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis Media name/outlet Tyler Morning Telegraph Country/Territory United States Date 19/05/24 URL https://tylerpaper.com/ap/business/new-phase-2a-clinical-trial-results-demonstrate-endeavor-biomedicines-env-101-improved-lung-function-and/article_2a260ece-ecdd-54ef-b82b-8caaa4d1d238.html Persons Michael Maher Title New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines’ ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis Media name/outlet WICZ Country/Territory United States Date 19/05/24 URL https://www.wicz.com/story/50803017/new-phase-2a-clinical-trial-results-demonstrate-endeavor-biomedicines-env-101-improved-lung-function-and-reversed-key-measures-of-lung-fibrosis-in Persons Michael Maher Title New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines’ ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis Media name/outlet HTV 10 - KFOL Country/Territory United States Date 19/05/24 URL https://www.htv10.tv/story/50803017/new-phase-2a-clinical-trial-results-demonstrate-endeavor-biomedicines-env-101-improved-lung-function-and-reversed-key-measures-of-lung-fibrosis-in Persons Michael Maher Title New Phase 2a Clinical Trial Results Demonstrate Endeavor BioMedicines’ ENV-101 Improved Lung Function and Reversed Key Measures of Lung Fibrosis in Patients With Idiopathic Pulmonary Fibrosis Media name/outlet 96.7 3WZ-FM Country/Territory United States Date 19/05/24 URL https://lifestyle.3wzfm.com/story/50803017/new-phase-2a-clinical-trial-results-demonstrate-endeavor-biomedicines-env-101-improved-lung-function-and-reversed-key-measures-of-lung-fibrosis-in Persons Michael Maher